RECRUITING

Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

Description

The objective of this study is to determine if using Fuzzy Wale compression stockinett can assist in reducing the healing time and decrease costs in trastibial amputation patients as compared to standard of care treatment compression stocking.

Conditions

Peripheral Arterial Disease
Talk to us

Related Conditions:

Peripheral Arterial Disease

Study Overview

On this page

Study Details

Study overview

The objective of this study is to determine if using Fuzzy Wale compression stockinett can assist in reducing the healing time and decrease costs in trastibial amputation patients as compared to standard of care treatment compression stocking.

A Pilot Study of Fuzzy Wale Compression Stockinet to Evaluate Healing Following Transtibial Amputation for Peripheral Arterial Disease

Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

Condition
Peripheral Arterial Disease
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \>18 years
  • * Male and female
  • * Transtibial amputation expected.
  • * Peripheral arterial disease and Transcutaneous partial pressure of oxygen (TCP02, if performed)
  • * Ability of subject to give appropriate consent or have an appropriate representative available to do so.
  • * Known allergies to any of the components of the compression.
  • * Terminal illness or current cancer therapy with chemotherapy
  • * Inability to undergo ongoing care in Rochester.
  • * Lack of cognitive ability to follow instructions or monitor residual limb.
  • * Vulnerable study population
  • * Pregnancy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Matthew Melin, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2025-12